Investors sue KaloBios Pharmaceuticals Inc. to return $5.4 million of their investment. The investors were brought in by Martin Shkreli. KaloBios Pharmaceuticals Inc. filed for bankruptcy in late December.
KaloBios Pharmaceuticals
Breaking News
Turing Pharmaceuticals said that it won't cut the list price of the drug. However, it will negotiate discount price with hospital. Last September, Turing Pharmaceuticals raised the price of live-saving drugs, Daraprim by more than fifty times.
Subscribe to VCpost newsletter
Most Popular
- Nestle Cuts Sales Forecast as Shoppers Reject Price Hikes
- Social Security Payments Worth Over $4,800 To Go Out This Week; Here’s When You’ll Get Yours
- US Could See Another ‘Great Resignation’ as 3 in 10 Workers Plan To Quit in 2024: Survey
- Uber, Lyft Drivers Remain as Contractors After California Supreme Court Upheld Proposition 22
- Maersk Agrees to Settlement with US Labor Department After Firing Whistleblower
- Walmart Eyes $200 Million Investment in Autonomous Forklifts
- Delta’s CEO Flew to Paris for the Olympics While His Company Is Under Federal Investigation: Report
- Murdoch Empire Family Feud Could Upend the Media Industry, Possibly End Fox News